skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Trends in clinical research in Japan, Asia-Pacific(Source:Alamy)

Dr Senthil Sockalingam, head, IQVIA Biotech, Japan-Asia Pacific (JAPAC) and chief medical officer, APAC, spoke to Scrip on trends and opportunities in the clinical research segment, partnering/outsourcing approaches and digitalization efficiencies, driven by the pandemic.

Rapid "virtualization" of the trials segment, how the regulatory framework in certain APAC markets is still catching up in this area, and adoption of telemedicine are some of the other key issues he delves into in this audio interview.

Sockalingam, a physician by training, also declared that artificial intelligence is the “new stethoscope or echocardiogram” and will only aid - not replace - doctors. There’s no need for them to become “nervous” he said.

Podcast Time Stamps

00:08 Introduction

00:58 IQVIA Biotech’s Latest Expansion In Japan/Asia Pacific

04:40 Diverse APAC Region, Oncology/Immunology Focus Of Biotechs, Partnering Models

11.53 Pandemic-Driven Virtualization Of Trials, Site Contracting Timelines

17:57 Digital Launch Efforts, Democratization Of Healthcare Providers’ Access To Information

21:25 Evolving Patient Journey

24:16 AI In Drug Development,Treatment

These and all our other podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud and TuneIn - and also now on Spotify Podcasts - and via smart speakers if one of these platforms has been set up as your default podcast provider. 

Related Stories:

https://scrip.pharmaintelligence.informa.com/SC144394/More-Small-Biotechs-Are-Launching-Drugs-On-Their-Own

https://scrip.pharmaintelligence.informa.com/SC143436/Indian-Trials-Recover-Amid-Lingering-Pandemic-Challenges

https://scrip.pharmaintelligence.informa.com/SC144125/AI-And-Tackling-Challenges-In-Clinical-Medicine

https://scrip.pharmaintelligence.informa.com/SC144058/Chinas-Internet-Hospitals-And-New-Commercial-Models-For-Pharma

https://scrip.pharmaintelligence.informa.com/SC142404/Commercial-Models-Shifting-As-Pharma-Mulls-Digital-First-Launches

https://scrip.pharmaintelligence.informa.com/SC144238/ISCRs-Davis-On-Pandemic-Adaptations-Value-Of-MultiRegional-Trials


Read also

;

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: